Open AccessLow molecular weight heparin in treating patients with lung cancer received chemotherapy
Author(s) -
Zili Liu,
Qian Wang,
Ming Wang,
Bin Wang,
Linian Huang
Publication year - 2018
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.176174
Subject(s) - medicine , cochrane library , lung cancer , relative risk , meta analysis , inclusion and exclusion criteria , incidence (geometry) , confidence interval , low molecular weight heparin , randomized controlled trial , hazard ratio , chemotherapy , surgery , heparin , pathology , alternative medicine , physics , optics
To systematically review the efficacy and safety of low molecular weight heparin (LMWH) in treating patients with lung cancer received chemotherapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom